ATE378334T1
Hepatitis c inhibitor compounds
Abstract
Compounds of formula (I): wherein B, X, R3, L0, L1, L2, R2, R1 and RC are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.
Term
Term ended
Projected expiry passed 19 May 2024, 2.3 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
1 priority claim, no other members on record
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 47270903 | United States of America | P |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 4733750
Titles2
- German
- VERBINDUNGEN ALS HEPATITIS C INHIBITOREN
- English
- COMPOUNDS AS HEPATITIS C INHIBITORS
Classification
- CPC, 12
- A61K31/4709
- C07D417/14
- A61K38/06
- A61K38/212
- C07K5/0808
- C07K5/0827
- A61P1/16
- A61P31/00
- A61P31/12
- A61P31/14
- A61P43/00
- Y02A50/30
- IPC, 6
- A61K31 4709
- A61K38 00
- A61K38 21
- A61P31 00
- C07K5 08
- C07K5 083